|
The Nasdaq Now: Apple, Amazon Move in Opposite Directions After Analyst Action
Minyanville.com Peregrine Pharmaceuticals (NASDAQ:PPHM) soared 71.85% to $ 2.32 after the company provided an update on the internal review of its phase II trial of its lung cancer treatment, bavituximab. The company was also upgraded to Buy from Neutral by Roth … |